Mylan Pharmaceuticals Maroc has launched operations at its new factory in Casablanca, which specializes in producing generic hepatitis C treatments.

The MPM, the Moroccan subsidiary of the American pharmaceutical giant Mylan Inc., will produce “Myhep All,” a generic medication for the treatment of hepatitis C.
The MPM, the Moroccan subsidiary of the American pharmaceutical giant Mylan Inc., will produce “Myhep All,” a generic medication for the treatment of hepatitis C.
Margot Eliason is a writer at Morocco World News.